| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ee2b4cf5180521e069e04d91bced4ff1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_08ae50d9d08a2ac1b4630cf80dbcb116 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2015-8518 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0694
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-785
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-7051
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-003
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K1-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y105-01003 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-785
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-435
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-07 |
| filingDate |
2018-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8734560adc13ab25cd79f888ec8eeab3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_33f9476c0a704cfa6b2a2f8559d4d58e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_79f3a08be816b837bab3b0fc284fb281
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_38322909710cb2317bfb5b305e42b418 |
| publicationDate |
2020-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
BR-112020004531-A2 |
| titleOfInvention |
methods, compositions and cells for preparing surfactant protein d (sp-d) |
| abstract |
some modalities of the methods and compositions provided here refer to the preparation of the surfactant protein-d (sp-d). some modalities include the expression of human sp-d in certain cell lines and the purification of human sp-d from these cell lines. some modalities include the preparation of certain oligomeric forms of human sp-d. |
| priorityDate |
2017-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |